Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252416
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2022-01-25
Brief Title:
VELA Study of BLU-222 in Advanced Solid Tumors
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-25
First Submit QC Date:
February 11 2022
Study First Post Date:
2022-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-23
Last Update Post Date Type:
ACTUAL